# Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics

> **NCT03238885** · — · COMPLETED · sponsor: **Sun Ying-Shi** · enrollment: 538 (actual)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** pelvic MR examination

## Key facts

- **NCT ID:** NCT03238885
- **Lead sponsor:** Sun Ying-Shi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-01
- **Primary completion:** 2018-12-18
- **Final completion:** 2019-01-21
- **Target enrollment:** 538 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03238885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03238885, "Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03238885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
